Prestige Consumer Healthcare IncChange company Symbol lookupSelect an option...PBH Prestige Consumer Healthcare IncBSQR Bsquare CorpAPYX Apyx Medical CorpXPEV Xpeng IncSTX Seagate Technology Holdings PLCEL Estee Lauder Companies IncCHND China Media IncBWG BrandywineGLOBAL ? Global Income Opportunities FundLCAAU L Catterton Asia Acquisition CorpGME GameStop CorpGo
Change company Symbol lookup
Select an option...
PBH Prestige Consumer Healthcare Inc
BSQR Bsquare Corp
APYX Apyx Medical Corp
XPEV Xpeng Inc
STX Seagate Technology Holdings PLC
EL Estee Lauder Companies Inc
CHND China Media Inc
BWG BrandywineGLOBAL ? Global Income Opportunities Fund
LCAAU L Catterton Asia Acquisition Corp
GME GameStop Corp
Health Care : Pharmaceuticals | Small Cap Blend
Company profilePrestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, TheraTears, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet Company, Incorporated, Care Pharmaceuticals Pty Limited, DenTek Holdings, Inc., Medtech Holdings, Inc., Peaks HBC Company, Inc. and others.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q4 ending 03/2022) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q4 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced May 5, 2022 | $0.91 | Q4 Estimate range of 6 analysts | $0.86 to $0.92 | Q1 Earnings will announce | (Unconfirmed) August 3, 2022 |
Quarterly Earnings History and Estimates
Hide high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
PBH's fiscal year ends in March
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.